MENVEO

Google image searchProduct monograph

Active ingredients

meningococcal group a oligosaccharide, 10 MCG/0.5 ML

meningococcal group c oligosaccharide, 5 MCG/0.5 ML

meningococcal group w-135 oligosaccharide, 5 MCG/0.5 ML

meningococcal group y oligosaccharide, 5 MCG/0.5 ML

corynebacterium diphtheriae crm-197 protein, 47 MCG/0.5 ML

DIN: 02347393

Dosage form(s): SOLUTION, POWDER FOR SOLUTION

Route(s) of administration: INTRAMUSCULAR

Description: 1 VIAL LYOPH. MEN. A CONJUGATE & 1 VIAL SOL. MEN. CWY CONJUGATE

Schedule: Schedule D

Company: GLAXOSMITHKLINE INC

Date: 27-MAR-2017

ATC:

• J07 — VACCINES (ATC, ATC/DDD, )
• J07A — BACTERIAL VACCINES (ATC, ATC/DDD)
• J07AH — Meningococcal vaccines (ATC, ATC/DDD)
• J07AH08 — MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN CONJUGATED (ATC/DDD)

External Links for Menveo

Search on Google

• Menveo side effects
• Menveo dosage
• meningococcal group a oligosaccharide side effects
• meningococcal group a oligosaccharide dosage
• meningococcal group c oligosaccharide side effects
• meningococcal group c oligosaccharide dosage
• meningococcal group w-135 oligosaccharide side effects
• meningococcal group w-135 oligosaccharide dosage
• meningococcal group y oligosaccharide side effects
• meningococcal group y oligosaccharide dosage
• corynebacterium diphtheriae crm-197 protein side effects
• corynebacterium diphtheriae crm-197 protein dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find menveo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.